Home
Eventide Asset Management reported a 0% stake in Zentalis Pharmaceuticals ZNTL · 0 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 0%
- Last report
- 6.28% · filed 25/02/14
- Shares held
- 0 sh
- Class
- Common Stock, $0.001 par value per share
- Event date
- 25/03/31
- Filed
- 25/05/13
0% stake · fully exited
- Stake
- 0%
- Last report
- 6.28%
- Since last report
- −6.3pp
Zentalis Pharmaceuticals trades, last 26 weeks
What else happened in Zentalis Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 25/03/01~25/04/30Eventide Asset Management's other 5% stake reports
- Eventide Asset Management
5% stakeOvid Therapeutics
5% stakeOvid Therapeutics
OVID
6.3% stake
11,812,241 sh
6.3% stake
Filed 08/14
- Eventide Asset Management
5% stakeImmix Biopharma
5% stakeImmix Biopharma
IMMX
5.6% stake
3,891,019 sh
5.6% stake
Filed 08/14
- Eventide Asset Management
5% stakeXometry
5% stakeXometry
XMTR
4% stake
2,151,845 sh
4% stake
Filed 08/14
- Eventide Asset Management
5% stakeOvid Therapeutics
5% stakeOvid Therapeutics
OVID
7.3% stake
12,773,577 sh
7.3% stake
Filed 05/15
- Eventide Asset Management
5% stakeBeta Bionics
5% stakeBeta Bionics
BBNX
13.4% stake
5,945,488 sh
13.4% stake
Filed 05/15
